Meet the alternative to ACL reconstruction — FDA grants de novo approval to implant

The FDA granted a de novo approval to Miach Orthopaedics’ Bridge-enhanced ACL Repair Implant, the company announced Dec. 17.

Advertisement

Physicians can use the implant to treat anterior cruciate ligament tears, a first-of-its-kind technology. Before the implant, surgeons had to surgically reconstruct a patient’s ACL.

Although reconstruction restores function, a patient’s knee is never the same.

This implant restores natural anatomy and function of the knee and is also less invasive. The implant, notably, doesn’t require surgeons to remove a tendon like reconstruction does.

Miach Orthopaedics plans to release the BEAR Implant to market in 2021.

More articles on surgery centers:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.